NCT02386397 2026-03-12
BREGO
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
Clinical Trials
4 trialsNCT05984602 2025-04-15
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
NYU Langone Health
Phase 1 Recruiting
NCT00390182 2020-03-18
GCC0319
University of Maryland, Baltimore
Phase 1/2 Completed
NCT02233205 2015-07-24
Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System
Peking University Cancer Hospital & Institute
Phase 1/2 Unknown